Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancerSHUIYING HU; DINGXIE LIU; CONDOURIS, Stephen et al.International journal of cancer. 2006, Vol 119, Num 10, pp 2322-2329, issn 0020-7136, 8 p.Article

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancerMINGZHAO XING; WESTRA, William H; TOLANEY, Sara et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 12, pp 6373-6379, issn 0021-972X, 7 p.Article

Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast CancerPROIA, David A; CHAOHUA ZHANG; SMITH, Donald L et al.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 413-424, issn 1078-0432, 12 p.Article

Phase II Trial of Bicalutamide in Patients with Androgen Receptor―Positive, Estrogen Receptor―Negative Metastatic Breast CancerGUCALP, Ayca; TOLANEY, Sara; STEARNS, Vered et al.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5505-5512, issn 1078-0432, 8 p.Article

Pneumocystis Carinii Pneumonia During Dose-Dense Chemotherapy for Breast CancerTOLANEY, Sara M; PARTRIDGE, Ann H; SHEIB, Rochelle G et al.Journal of clinical oncology. 2006, Vol 24, Num 33, pp 5330-5331, issn 0732-183X, 2 p.Article

Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstructionKANSAL, Kari Joanne; DOMINICI, Laura Stewart; TOLANEY, Sara M et al.Breast cancer research and treatment. 2013, Vol 141, Num 2, pp 255-259, issn 0167-6806, 5 p.Article

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practiceRUDDY, Kathryn J; DESANTIS, Stephen D; GELMAN, Rebecca S et al.Breast cancer research and treatment. 2013, Vol 141, Num 3, pp 421-427, issn 0167-6806, 7 p.Article

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancerLIU, Joyce F; TOLANEY, Sara M; IVY, Percy et al.European journal of cancer (1990). 2013, Vol 49, Num 14, pp 2972-2978, issn 0959-8049, 7 p.Article

Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2―Dependent and Other Solid TumorsGANDHI, Leena; BAHLEDA, Rastislav; KRYGOWSKI, Mizue et al.Journal of clinical oncology. 2014, Vol 32, Num 2, pp 68-75, issn 0732-183X, 8 p.Article